These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10965482)

  • 1. [Decreased activity of 11-beta-hydroxysteroid dehydrogenase in patients with Cushing's syndrome].
    Stiefel P; Jiménez L; García-Morillo JS; Leal A; Villar J; Carneado J
    Med Clin (Barc); 2000 Jun; 115(3):90-2. PubMed ID: 10965482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M; Shackleton CH; Mantero F; Stewart PM
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.
    Stiefel P; García-Morillo JS; Jimenez L; Pamies E; Miranda ML; Carneado J; Villar J; Leal-Cerro A
    Endocrine; 2002 Aug; 18(3):279-84. PubMed ID: 12450320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
    Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
    Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.
    Torpy DJ; Mullen N; Ilias I; Nieman LK
    Ann N Y Acad Sci; 2002 Sep; 970():134-44. PubMed ID: 12381548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome.
    Walker BR; Campbell JC; Fraser R; Stewart PM; Edwards CR
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):483-92. PubMed ID: 1337504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11beta-hydroxysteroid dehydrogenase activity in proteinuric patients and the effect of angiotensin-II receptor blockade.
    Kerstens MN; Buter H; Navis GJ; Dullaart RP
    Eur J Clin Invest; 2002 Jul; 32(7):513-8. PubMed ID: 12153552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of urinary metabolites of cortisol in eluates from thin-layer chromatograms obtained by the partition method.
    Butruk E
    Mater Med Pol; 1972; 4(4):226-35. PubMed ID: 4361141
    [No Abstract]   [Full Text] [Related]  

  • 10. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M; Delitala G; Sorba G; Cossu M; Satta R; Tedde R; Pala A; Shackleton CH
    J Endocrinol Invest; 2000; 23(7):457-62. PubMed ID: 11005270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome.
    Phillipou G
    Clin Endocrinol (Oxf); 1982 May; 16(5):433-9. PubMed ID: 7083597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome.
    Lin CL; Wu TJ; Machacek DA; Jiang NS; Kao PC
    J Clin Endocrinol Metab; 1997 Jan; 82(1):151-5. PubMed ID: 8989250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
    Finken MJ; Andrews RC; Andrew R; Walker BR
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC-ESI-MS/MS assessment of the tetrahydro-metabolites of cortisol and cortisone in bovine urine: promising markers of dexamethasone and prednisolone treatment.
    Chiesa L; Panseri S; Pavlovic R; Cannizzo FT; Biolatti B; Divari S; Villa R; Arioli F
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016 Jul; 33(7):1175-89. PubMed ID: 27310211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic changes in serum steroids for diagnosing and subtyping Cushing's syndrome.
    Ahn CH; Lee C; Shim J; Kong SH; Kim SJ; Kim YH; Lee KE; Shin CS; Kim JH; Choi MH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105856. PubMed ID: 33647522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary cortisol to cortisone metabolites in hypertensive obese children.
    Csábi GY; Juricskay S; Molnár D
    J Endocrinol Invest; 2000; 23(7):435-9. PubMed ID: 11005267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
    Stewart PM; Burra P; Shackleton CH; Sheppard MC; Elias E
    J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
    Walker BR; Andrew R; MacLeod KM; Padfield PL
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.